| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 6 | +435K | 100% | $1.87 | +$814K |
| Sells | 0 | ||||
| Net | +6 | +435K | 100% | +$814K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Lantheus Alpha Therapy, LLC | 10%+ Owner | $111M | Mar 6, 2024 | ||
| Lori A. Woods | Director | $401K | +$100K | +33.2% | Mar 31, 2025 |
| Robert F. Williamson III | Director | $234K | +$248K | Mar 28, 2025 | |
| Johan M. Spoor | Chief Executive Officer, Director | $194K | +$207K | Mar 28, 2025 | |
| Jonathan Hunt | Chief Accounting Officer | $189K | +$84K | +79.7% | Mar 3, 2025 |
| Heidi Henson | Director | $100K | +$100K | Mar 3, 2025 | |
| Juan Graham | Chief Financial Officer | $79.5K | +$74.9K | +1649% | Mar 28, 2025 |
| Mark Austin | VP Finance/Prin Fin&Acct Offic | $30.3K | Jul 17, 2024 | ||
| Jennifer Streeter | COO & VP of HR | $25.6K | Jun 12, 2023 | ||
| Philip J. Vitale | Director | Jul 21, 2022 | |||
| Alan Hoffmann | Director | Jul 21, 2022 | |||
| William Cavanagh | Chief R&D Officer | Jul 21, 2022 | |||
| Markus Puhlmann | Chief Medical Officer | Mar 3, 2025 | |||
| Michael McCormick | Director | Feb 21, 2023 | |||
| Frank Morich | Director | Mar 3, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|